HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diphenylhydantoin induced granulocytopenia following a seizure prophylaxis after a depressed skull fracture.

Abstract
The article deals with a rare case of granulocytopenia following a seizure prophylaxis after a severe head injury. Although fatal complications like the one described occur extremely seldom, we want to emphasize the necessity of regular controls during the critical time period between the 10th and the 67th day of diphenylhydantoin treatment. The blood level should not exceed 10-20 micrograms/ml to prevent any toxic reaction to the myelopoetic system. If this treatment cannot be provided, we suggest to administer Clonazepam or Convulex.
AuthorsM Gabl, H Kostron
JournalZentralblatt fur Neurochirurgie (Zentralbl Neurochir) Vol. 47 Issue 4 Pg. 339-41 ( 1986) ISSN: 0044-4251 [Print] Germany
PMID3105193 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Phenytoin
Topics
  • Aged
  • Agranulocytosis (chemically induced)
  • Brain Concussion (complications)
  • Epilepsy, Post-Traumatic (prevention & control)
  • Humans
  • Male
  • Parietal Bone (injuries)
  • Phenytoin (adverse effects, therapeutic use)
  • Skull Fractures (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: